These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16866713)

  • 21. Correlation between CGRP and migraine attacks.
    Edvinsson L
    Cephalalgia; 2005 Mar; 25(3):163-4. PubMed ID: 15689190
    [No Abstract]   [Full Text] [Related]  

  • 22. Involvement of capsaicin-sensitive afferent nerves in the proteinase-activated receptor 2-mediated vasodilatation in the rat dura mater.
    Dux M; Rosta J; Sántha P; Jancsó G
    Neuroscience; 2009 Jul; 161(3):887-94. PubMed ID: 19362118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocretins and primary headaches: neurobiology and clinical implications.
    Rainero I; De Martino P; Pinessi L
    Expert Rev Neurother; 2008 Mar; 8(3):409-16. PubMed ID: 18345971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nitric oxide donors on the central nervous system--nitroglycerin studies in the rat.
    Tassorelli C; Costa A; Blandini F; Joseph SA; Nappi G
    Funct Neurol; 2000; 15 Suppl 3():19-27. PubMed ID: 11200790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The mechanism of peripheral and central sensitization in migraine. A literature review].
    Tajti J; Vécsei L
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):15-21. PubMed ID: 19731814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of BoNT-A in the treatment of migraine and its ability to repress CGRP release.
    Caputi CA
    Headache; 2004 Sep; 44(8):837-8. PubMed ID: 15330838
    [No Abstract]   [Full Text] [Related]  

  • 27. Sensory nerves in man and their role in primary headaches.
    Edvinsson L
    Cephalalgia; 2001 Sep; 21(7):761-4. PubMed ID: 11595008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PACAP38: Emerging Drug Target in Migraine and Cluster Headache.
    Vollesen ALH; Ashina M
    Headache; 2017 May; 57 Suppl 2():56-63. PubMed ID: 28485845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
    Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
    Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxic mechanisms in primary headaches.
    Britze J; Arngrim N; Schytz HW; Ashina M
    Cephalalgia; 2017 Apr; 37(4):372-384. PubMed ID: 27146279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: Nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients.
    Eli R; Fasciano JA
    Med Hypotheses; 2006; 66(3):461-5. PubMed ID: 16298494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary sensory neurons containing choline acetyltransferase of the peripheral type in the rat trigeminal ganglion and their relation to neuropeptides-, calbindin- and nitric oxide synthase-containing cells.
    Yasuhara O; Aimi Y; Shibano A; Kimura H
    Brain Res; 2007 Apr; 1141():92-8. PubMed ID: 17291466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding new drug targets for the treatment of migraine attacks.
    Olesen J; Tfelt-Hansen P; Ashina M
    Cephalalgia; 2009 Sep; 29(9):909-20. PubMed ID: 19250288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elusive amines and primary headaches: historical background and prospectives.
    D'Andrea G; Terrazzino S; Fortin D; Cocco P; Balbi T; Leon A
    Neurol Sci; 2003 May; 24 Suppl 2():S65-7. PubMed ID: 12811595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin gene-related peptide: a marker for putative primary afferent neurons in the pig small intestinal myenteric plexus?
    Wolf M; Schrödl F; Neuhuber W; Brehmer A
    Anat Rec (Hoboken); 2007 Oct; 290(10):1273-9. PubMed ID: 17763367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenic inflammation in primary headaches.
    Fusco M; D'Andrea G; Miccichè F; Stecca A; Bernardini D; Cananzi AL
    Neurol Sci; 2003 May; 24 Suppl 2():S61-4. PubMed ID: 12811594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers associated with migraine and their potential role in migraine management.
    Durham P; Papapetropoulos S
    Headache; 2013 Sep; 53(8):1262-77. PubMed ID: 23848170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview on immune system and migraine.
    Bruno PP; Carpino F; Carpino G; Zicari A
    Eur Rev Med Pharmacol Sci; 2007; 11(4):245-8. PubMed ID: 17876959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroprotective action of orexin-A against stress-induced gastric damage is mediated by endogenous prostaglandins, sensory afferent neuropeptides and nitric oxide.
    Brzozowski T; Konturek PC; Sliwowski Z; Drozdowicz D; Burnat G; Pajdo R; Pawlik M; Bielanski W; Kato I; Kuwahara A; Konturek SJ; Pawlik WW
    Regul Pept; 2008 Jun; 148(1-3):6-20. PubMed ID: 18378017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.